...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Pre IPO?!!
1
Dec 13, 2017 10:05AM

Zenith IPO for  Zen3694 only or Zenith Epigenetics I wonder what they are thinking , ( would be a big difference in shareholder valuation between the entire Zenith Epi  platform IPO  and or an IPO on one indication only to start.

Would love to just see an IPO for just Zen 3694 then IPO all the other indications separately  , One can dream of what Zenith Capital corp shares are worth if that is the case

Share
New Message
Please login to post a reply